Cash Flow Statement

Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Interest Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt repayments

Daily Values

Growth Metrics

Others

Prokidney (PROK) Asset Writedowns and Impairment (2024 - 2025)

Prokidney (PROK) has disclosed Asset Writedowns and Impairment for 2 consecutive years, with $318000.0 as the latest value for Q3 2025.

Quarterly Asset Writedowns and Impairment fell 94.03% to $318000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $318000.0 through Dec 2025, down 94.03% year-over-year, with the annual reading at $318000.0 for FY2025, 94.03% down from the prior year.
Asset Writedowns and Impairment for Q3 2025 was $318000.0 at Prokidney, down from $5.3 million in the prior quarter.
The five-year high for Asset Writedowns and Impairment was $5.3 million in Q3 2024, with the low at $318000.0 in Q3 2025.